Scott J. Rodig

Scott J. Rodig is a Professor of Pathology at Harvard Medical School, with affiliations at the Dana-Farber Cancer Institute and Brigham and Women's Hospital. His clinical expertise lies in Anatomic Pathology and Hematopathology, supported by board certifications in these fields since 2002. He specializes in Hematologic Oncology and CNS Lymphoma research, contributing to advancements in cancer diagnostics and treatment strategies.

Education:

• Medical Doctorate (MD) from Washington University School of Medicine
• PhD in an unspecified field (implied by credentials)

Research Interests: Dr. Rodig focuses on molecular pathology, tumor biology, and translational research in lymphoma and hematologic malignancies. His work integrates immunology and oncology to develop precision medicine approaches and improve diagnostic tools. He collaborates closely with clinical teams to translate laboratory findings into patient care.

Awards: Notable recognition includes being named among the Dana-Farber Cancer Institute faculty among world's most highly cited researchers in 2024, highlighting his impactful contributions to the field.

Advising & Grants: While specific advisees or grant details are not listed, his academic role suggests involvement in training future pathologists and leading research projects. He is affiliated with key centers:

• Hematologic Oncology Center
• CNS Lymphoma Center

Labs/Teams: Collaborates within Dana-Farber’s research teams, particularly in lymphoma and cancer pathology initiatives. His work aligns with interdisciplinary efforts in oncology and molecular diagnostics.